CSF1 and ovarian cancer: Furthermore, hypermethylation of miRNA-130b was found to be linked to ovarian cancer tumorigenesis and drug resistance, while miRNA-130b restoration sensitized ovarian cancer cells to taxol and CDDP, using colony-stimulating factor 1 (CSF1) as a direct target [130].